Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.393, 2002-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Test-and-treat strategy for dyspepsia beneficial in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 361, 2002-01 ,pp. :
Access to resources
Recommend
Isoniazid cost saving vs rifampicin/pyrazinamide in latent TB
Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. :
Isoniazid cost saving vs rifampicin/pyrazinamide in latent TB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :
Paliperidone potentially cost saving in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :
Pneumococcal conjugate vaccine potentially cost saving in the US
Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. :